Abstract
Background: Caveolin-1 (CAV1) is a master regulator of cell signaling and membrane transport. CAV1 has been implicated in breast cancer oncogenesis and metastasis and may be a potential prognosticator, especially for non-distant recurrences. Several CAV1 SNPs have been linked to other cancers, however, the prognostic impact of CAV1 SNPs in breast cancer remains unclear. Here, we investigated CAV1 haplotypes association with clinical outcomes in breast cancer.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
